Rhumbline Advisers Acrivon Therapeutics, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 17,760 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,760
Previous 16,209 9.57%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
N/A
1,551 Added 9.57%
17,760 $0
Q2 2024

Aug 01, 2024
BUY
N/A
5,320 Added 48.86%
16,209 $0
Q1 2024

May 09, 2024
BUY
N/A
1,619 Added 17.46%
10,889 $0
Q4 2023

Feb 08, 2024
SELL
N/A
-207 Reduced 2.18%
9,270 $0
Q3 2023

Nov 09, 2023
BUY
N/A
491 Added 5.46%
9,477 $0
Q2 2023

Aug 08, 2023
BUY
N/A
8,986 New
8,986 $0

Others Institutions Holding ACRV

# of Institutions
53
Shares Held
23.2M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email